| HOME >> BIOLOGY >> TECHNOLOGY |
Cost of consumer
products sold 995,769 675,101 2,882,072 675,101
Research and
development 785,942 721,731 2,246,340 2,382,390
Selling, general and
administrative 1,163,531 1,196,263 4,821,032 2,702,517
Amortization of
intangibles 413,209 145,322 1,236,074 193,830
Total operating
costs and
expenses 3,570,404 3,070,253 11,906,608 6,891,608
Loss from operations (1,009,119) (1,735,322) (4,517,578) (3,979,763)
Total other income and
expense, net (68,540) (98,327) (188,680) (366,546)
Net loss before income
taxes (1,077,659) (1,833,649) (4,706,258) (4,346,309)
Provision for income
taxes (4,000) - (12,000) -
Net loss $(1,081,659) $(1,833,649) $(4,718,258) $(4,346,309)
Net loss per basic and
diluted common share $(0.04) $(0.07) $(0.17) $(0.18)
Weighted average
common shares
outstanding 27,637,303 25,702,739 27,576,940 24,653,698
| SOURCE Interleukin Genetics, Inc. Copyright©2007 PR Newswire. All rights reserved |